False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor StudyS Kleinman
Westat Inc, Rockville, MD, USA
JAMA 280:1080-5. 1998
..Persons at risk of human immunodeficiency virus 1 (HIV-1) infection, have been classified incorrectly as HIV infected because of Western blot results, but the frequency of false-positive Western blot results is unknown...
Research, monitoring, and policy issues related to emerging pathogensSteven Kleinman
U. British Columbia, Vancouver, BC, Canada
Vox Sang 83:351-4. 2002
Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screeningSteven H Kleinman
Westat, Rockville, Maryland, USA
Transfusion 43:696-704. 2003
..An estimate of the rate of HBV DNA-positive, anti-HBc-positive units is important for evaluating the need for anti-HBc donor screening, especially in the context of HBV NAT...
Hepatitis G virus biology, epidemiology, and clinical manifestations: Implications for blood safetyS Kleinman
University of British Columbia, Vancouver, British Columbia, Canada
Transfus Med Rev 15:201-12. 2001
..Because the data do not indicate any pathologic effects of HGV, it is not appropriate to screen the blood supply for HGV RNA...
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donorsB Wang
Westat, Rockville, Maryland 20850, USA
Transfusion 44:1243-51. 2004
..Little is known, however, about the impact of indefinite deferral of transfused donors on blood safety and availability in the US...
Initiatives to improve blood donor screeningS Kleinman
Professor of Clinical Pathology, University of British Columbia, Vancouver, BC, Canada
Dev Biol (Basel) 120:67-75. 2005
Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?Baoguang Wang
Westat, Rockville, Maryland 20850, USA
Transfusion 45:1089-96. 2005
..Prevalence, however, is readily available. Understanding whether prevalence reflects corresponding incidence may help blood centers monitor disease risks...
AABB survey of transfusion-related acute lung injury policies and practices in the United StatesPatricia Kopko
Histocompatibility Laboratory, BloodSource, Sacramento, California, USA
Transfusion 47:1679-85. 2007
..Policies and practices with regard to transfusion-related acute lung injury (TRALI) diagnosis, laboratory investigation of TRALI cases, and donor deferral and donor management are not standardized...
The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United StatesEleftherios C Vamvakas
Canadian Blood Services; Department of Pathology and Laboratory Medicine, University of Ottawa Faculty of Medicine, ON, Canada
Transfus Med Rev 20:97-109. 2006
..This review discusses the guiding principles affecting CBS policy development and compares CBS WNV safety policies to policies adopted in the United States...
Promoting recognition and prevention of transfusion-related acute lung injurySteven Kleinman
AABB (American Association of Blood Banks, Bethesda, MD 20814-2749, USA
Crit Care Nurse 27:49-53. 2007
Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donorsMichael P Busch
Blood Systems Research Institute, San Francisco, California 94118, USA
Transfusion 46:469-75. 2006
..Factors associated with resolution of viremia are not well defined. Implementation of routine nucleic acid testing (NAT) of blood donors has yielded a large data set for analysis of demographic correlates of resolved viremia...
A perspective on transfusion-related acute lung injury two years after the Canadian Consensus ConferenceSteven Kleinman
Transfusion 46:1465-8. 2006
The 2003 West Nile virus United States epidemic: the America's Blood Centers experienceSteven Kleinman
Westat, Rockville, Maryland, USA
Transfusion 45:469-79. 2005
..This study demonstrates that a national collaborative effort facilitates timely surveillance of blood donor infectious disease prevalence rates...
Toward an understanding of transfusion-related acute lung injury: statement of a consensus panelSteven Kleinman
Kleinman Biomedical Research, Victoria, British Columbia, Canada
Transfusion 44:1774-89. 2004
The donor notification process from the donor's perspectiveSteven Kleinman
Westat, Rockville, Maryland, USA
Transfusion 44:658-66. 2004
..Despite large numbers of blood donors being notified of abnormal infectious disease screening results, there has been little scientific study of the effects of this process...
Survival after transfusion as assessed in a large multistate US cohortSteven Kleinman
Kleinman Biomedical Research, 1281 Rockcrest Avenue, Victoria, British Columbia V9A 4W4, Canada
Transfusion 44:386-90. 2004
..The only survival and mortality data on a general population of transfused patients in the United States is more than two decades old. More contemporary data are needed to reflect more current patient populations and transfusion practices...
Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectivesF Blaine Hollinger
Baylor College of Medicine, Houston, Texas, USA
Transfusion 43:992-7. 2003
Risks associated with transfusion of cellular blood components in CanadaSteven Kleinman
University of British Columbia, Vancouver BC, Canada
Transfus Med Rev 17:120-62. 2003
..These estimates are useful for decisions concerning transfusion therapy, the informed consent process, and for evaluating efficacy of interventions to reduce risk...
Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assayAnuradha Pai
From Roche Molecular Systems, Pleasanton, California 94588, USA
Transfusion 48:2184-9. 2008
..A series of studies established the performance characteristics of the assay and test system before FDA licensure...